ArticleInfection and drug resistance2026
Lymphopenia is Associated with Altered Pathogen Distribution and Increased Disease Severity in Viral Pneumonia: A Multicenter Retrospective Cohort Study.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lymphopenia is common in viral pneumonia and has been associated with adverse outcomes. However, its relationship with pathogen distribution, mixed infections, and opportunistic infections across different immune statuses remains incompletely characterized. Methods: We conducted a multicenter retrospective cohort study including 2363 adult patients hospitalized with viral pneumonia, of whom 690 were immunocompromised. Patients were stratified into four groups according to immune status and lymphocyte count on admission. Clinical characteristics, laboratory parameters, pathogen profiles, and clinical outcomes were compared across groups. Multivariable logistic regression analyses were performed to identify factors independently associated with in-hospital mortality. Results: Patients with lymphopenia had more severe clinical presentations, higher inflammatory and coagulation markers, and increased severity scores than those without lymphopenia. Across both immune-status strata, patients with lymphopenia had higher observed rates of respiratory failure, invasive mechanical ventilation, ECMO, and in-hospital mortality than those without lymphopenia. Pathogen analyses demonstrated marked differences in pathogen distribution across groups. Immunocompromised patients with lymphopenia showed significantly higher proportions of bacterial co-infections, fungal infections, and mixed infections, particularly involving Aspergillus flavus, Pneumocystis jirovecii, Conclusion: Lymphopenia is associated with altered pathogen distribution, increased mixed and opportunistic infections, and worse clinical outcomes in viral pneumonia, independent of underlying immune status. Lymphocyte count represents a readily available clinical marker reflecting immune dysfunction and infection complexity, highlighting the need for heightened vigilance and comprehensive pathogen evaluation in patients with viral pneumonia and lymphopenia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.